BIRC5 and carcinoma: Interestingly, our findings indicated that presence of pERK1-2 expression in primary T4 carcinomas may be indeed correlated with clinical outcome (see Figure 2), suggesting that the cascade of molecular events activating ERK1-2 and upregulating survivin has indeed an important prognostic role in such patients.